Holen Sie sich die Stockscreener-App
5.10
1.55%
-0.06
Schlusskurs vom Vortag:
$5.16
Offen:
$5.16
24-Stunden-Volumen:
99,224
Relative Volume:
0.08
Marktkapitalisierung:
$557.85M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-134.24M
KGV:
-2.5758
EPS:
-1.98
Netto-Cashflow:
$-121.34M
1W Leistung:
-19.75%
1M Leistung:
-32.09%
6M Leistung:
+5.83%
1J Leistung:
+100.79%
1-Tages-Spanne:
$5.06
$5.24
1-Wochen-Bereich:
$5.045
$6.49
52-Wochen-Spanne:
$2.27
$8.40
Annexon Inc Stock (ANNX) Company Profile
Firmenname
Annexon Inc
Sektor
Branche
Telefon
(650)-822-5500
Adresse
1400 SIERRA POINT PARKWAY, BRISBANE
Vergleichen Sie ANNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ANNX | 5.10 | 557.85M | 0 | -134.24M | -121.34M | -1.98 |
| VRTX | 447.53 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 741.03 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.31 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.73 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.47 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-09-16 | Eingeleitet | Jefferies | Buy |
| 2022-09-09 | Eingeleitet | BTIG Research | Buy |
| 2021-11-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-01-26 | Eingeleitet | Needham | Buy |
| 2020-08-18 | Eingeleitet | BofA Securities | Buy |
| 2020-08-18 | Eingeleitet | Cowen | Outperform |
| 2020-08-18 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Annexon Inc Aktie (ANNX) Neueste Nachrichten
Insiders Enjoy US$903k Return After Buying Annexon Stock - Simply Wall St
The Dodgers’ World Series run brought attention to a rare disease. Annexon is stepping up to the plate. - Yahoo Finance
HC Wainwright Has Negative View of Annexon FY2027 Earnings - MarketBeat
Annexon (NASDAQ:ANNX) Earns “Buy” Rating from HC Wainwright - Defense World
Annexon (NASDAQ:ANNX) Earns “Overweight” Rating from Cantor Fitzgerald - Defense World
Financial Contrast: Annexon (NASDAQ:ANNX) & Acasti Pharma (NASDAQ:ACST) - Defense World
Annexon, Inc. (NASDAQ:ANNX) Short Interest Down 12.9% in October - MarketBeat
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Annexon Grants 495,000 Stock Options to New Employees in Talent Acquisition Push | ANNX Stock News - StockTitan
Annexon's (ANNX) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Annexon's (ANNX) Buy Rating Reiterated at HC Wainwright - MarketBeat
Annexon (NASDAQ:ANNX) Given "Buy" Rating at Needham & Company LLC - MarketBeat
Logos Global Management LP Adjusts Stake in Annexon Inc - GuruFocus.com
Annexon Biosciences Reports Q3 Financial Results - TipRanks
Annexon Inc (ANNX) Quarterly 10-Q Report - Quartzy
Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones - GlobeNewswire
Annexon, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Annexon Biosciences to Present at the Jefferies London Healthcare Conference - GlobeNewswire
FMR LLC's Strategic Acquisition of Annexon Inc Shares - GuruFocus.com
Creative Planning Has $206,000 Stake in Annexon, Inc. (NASDAQ:ANNX) - Defense World
Analysts Set Annexon, Inc. (NASDAQ:ANNX) Price Target at $15.80 - MarketBeat
JP Morgan Upgrades Annexon (ANNX) - MSN
Annexon shares positive on ARCHER trial data, analyst maintains Buy rating - Investing.com
Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less - The Bakersfield Californian
Annexon Presents Phase 2 Vision Preservation Data with - GlobeNewswire
We're Hopeful That Annexon (NASDAQ:ANNX) Will Use Its Cash Wisely - Yahoo Finance
Tracking Annexon's Progress On Therapies For Complement-mediated Diseases - RTTNews
Annexon EVP Ted Yednock sells $40,073 in stock - Investing.com
Annexon EVP Ted Yednock sells $40,073 in stock By Investing.com - Investing.com South Africa
Insider Selling: Annexon, Inc. (NASDAQ:ANNX) EVP Sells 5,408 Shares of Stock - MarketBeat
Where are the Opportunities in (ANNX) - Stock Traders Daily
A better buy-in window may exist right now for Annexon Inc (ANNX) - SETE News
Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting - The Manila Times
Annexon to Present New Phase 2 ARCHER Data for ANX007 in - GlobeNewswire
Annexon Inc (ANNX) stock: A year of ups and downs - US Post News
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Buy" by Brokerages - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Short Interest Update - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Sees Significant Growth in Short Interest - MarketBeat
Eli Lilly and Company (NYSE:LLY) & Annexon (NASDAQ:ANNX) Head to Head Survey - Defense World
A Bullish 2024 Outlook For Annexon Inc (NASDAQ: ANNX) Shares - Stocks Register
Annexon, Inc. (NASDAQ:ANNX) Shares Purchased by AQR Capital Management LLC - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
Recent Insider Activity Could Benefit Annexon Inc (ANNX) - Knox Daily
Views of Wall Street’s Leading Experts on Annexon Inc - SETE News
Annexon (NASDAQ:ANNX) Shares Up 4.7%What's Next? - MarketBeat
Annexon Inc (NASDAQ: ANNX) Could Fell Another -130.26% - Stocks Register
Is Annexon Inc (ANNX) a opportunity to investors? - US Post News
Annexon Inc (ANNX) Stock: A Year of Decreases and Increases - The InvestChronicle
Susquehanna Fundamental Investments LLC Purchases 129,455 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon, Inc. (NASDAQ:ANNX) Shares Acquired by Susquehanna Fundamental Investments LLC - MarketBeat
Director William Carson Acquires 3,200 Shares of Annexon Inc (AN - GuruFocus.com
Finanzdaten der Annexon Inc-Aktie (ANNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):